Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Xeris Biopharma Holdings, Inc. (XERS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1200-0.0600 (-2.75%)
At close: 04:00PM EST
2.0800 -0.04 (-1.89%)
After hours: 06:27PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.1800
Open2.0200
Bid2.0700 x 3000
Ask2.1200 x 1800
Day's Range1.9600 - 2.1300
52 Week Range1.7700 - 7.9400
Volume2,702,670
Avg. Volume3,238,746
Market Cap264.383M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.5140
Earnings DateMar 07, 2022 - Mar 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for XERS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Xeris Biopharma Holdings, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement